BMGL
Basel Medical Group Ltd Ordinary Shares
NASDAQ: BMGL · HEALTHCARE · MEDICAL CARE FACILITIES
$0.58
+3.55% today
Updated 2026-04-30
Market cap
$11.65M
P/E ratio
—
P/S ratio
1.03x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $7
Volume
0.0M
Basel Medical Group Ltd Ordinary Shares (BMGL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $10.66M | $9.70M | $10.05M | $11.32M |
| Revenue growth (YoY) | — | -9.0% | +3.6% | +12.6% |
| Cost of revenue | $2.18M | $2.34M | $2.25M | $2.53M |
| Gross profit | $8.48M | $7.36M | $7.80M | $8.79M |
| Gross margin | 79.6% | 75.9% | 77.6% | 77.7% |
| R&D | — | — | — | — |
| SG&A | $4.04M | $3.27M | $3.64M | $6.54M |
| Operating income | $2.47M | $2.00M | $2.20M | $-2.18M |
| Operating margin | 23.2% | 20.6% | 21.8% | -19.3% |
| EBITDA | $3.28M | $2.93M | $3.11M | $-11.12M |
| EBITDA margin | 30.8% | 30.2% | 30.9% | -98.2% |
| EBIT | $2.71M | $2.37M | $2.58M | $-12.30M |
| Interest expense | $320867.00 | $238602.00 | $176238.00 | $203948.00 |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1.98M | $1.78M | $2.07M | $-12.09M |
| Net income growth (YoY) | — | -9.8% | +16.2% | -683.2% |
| Profit margin | 18.6% | 18.4% | 20.6% | -106.8% |